Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 36 - Advisory Commission on Childhood Vaccines - Statutory (Congress Created)


Committee NameAdvisory Commission on Childhood VaccinesAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number36
Original Establishment Date10/1/1988Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*13
Current Charter Date7/21/2022Designated Fed Officer Position Title*Division Director, Division of Injury Compensation Programs
Date Of Renewal Charter7/21/2024Designated Federal Officer PrefixCDR
Projected Termination Date Designated Federal Officer First Name*Reed
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Grimes
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixMD, MPH
Specific Establishment Authority*42 U.S.C. 300aa-19Designated Federal Officer Phone*(301) 945-5820
Effective Date Of Authority*10/1/1988Designated Federal Officer Fax*(301) 443-0704
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*National Policy Issue Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Advisory Commission on Childhood Vaccines (ACCV) accomplishes its purpose by meeting in full session and establishing special topic workgroups. In Fiscal Year (FY) 2022, the ACCV continued to meet and have discussions on topics regarding the National Vaccine Injury Compensation Program (VICP). Each meeting included representatives from various federal government agencies, as well as other stakeholders (i.e. vaccine manufacturer, petitioner’s attorney).
How is membership balanced?*The ACCV members consist of three health professionals who are not employees of the federal government, and who have expertise in the health care of children, the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines, of whom at least two are pediatricians; three members from the general public, of whom at least two shall be legal representatives of children who have suffered a vaccine-related injury or death; and three attorneys, of whom at least one is an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death and one who is an attorney whose specialty includes representation of vaccine manufacturers.
How frequent & relevant are cmte mtgs?*The ACCV meets four times a calendar year to advise the Secretary of HHS on matters related to the implementation of the VICP. In calendar year 2022 the ACCV will meet four times; however, only three meetings are captured for FY 2022.
Why advice can't be obtained elsewhere?*The ACCV members represent the various stakeholders that have an interest in the VICP, and provide scientific, legal and practical advice and recommendations to the Secretary of HHS. This expertise is not available within HHS.
Why close or partially close meetings?N/A. Meetings are open to the public.
Recommendation RemarksACCV member William Spiegel's term end date changed from 5/10/2023 to 5/17/2022 because he resigned from the ACCV on 5/17/2022, thus ending his service on ACCV. The ACCV March 2022 Meeting has been rescheduled for Friday, December 2, 2022, and is outside of FY 2022.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationYes
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentIn FY 2022 the ACCV did not recommend and the HHS Secretary did not approve or request any changes to the VICP regarding reorganizing priorities or reallocating resources. There have been no new regulations issued for the VICP this fiscal year. The VICP does not use grants.
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Under $100,000Dollar Value Of Grants Recommended$0.00
Cost Savings CommentThe ACCV held all of the FY 22 meetings virtually. Therefore no travel reimbursements were made in FY 22.Grants Review CommentNA
Number Of Recommendations*63Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThese recommendations provide advice to the Secretary of HHS regarding the VICP.Access Agency WebsiteYes
% of Recs Fully Implemented*44.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThese recommendations have been implemented to improve aspects of the VICP. No new recommendations were made in FY 22 but recommendations made in previous years were implemented.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*5.00%Access PublicationsNo
% of Recs Partially Implemented CommentThese recommendations have been implemented to improve aspects of the VICP.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*The Secretary of HHS acknowledges receipt of the ACCV recommendations, and thanks the ACCV for providing advice and recommendations on the VICP. The public can obtain information on agency feedback at the ACCV website: Description*The ACCV provides advice and makes recommendations to the Secretary of HHS regarding the VICP.
Hide Section - COSTS


Payments to Non-Federal Members*$7,176.00Est Payments to Non-Fed Members Next FY*$7,176.00
Payments to Federal Members*$22,693.00Est. Payments to Fed Members Next FY*$23,845.00
Payments to Federal Staff*$266,016.00Estimated Payments to Federal Staff*$245,470.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$3,550.00Est. Other Costs Next FY*$7,200.00
Total Costs$299,435.00Est. Total Next FY*$283,691.00
Date Cost Last Modified11/4/2022 10:38 AMEst. Fed Staff Support Next FY*1.30
Federal Staff Support (FTE)*1.50Est Cost Remarksother costs include and estimated increase in producing recording and transcripts.
Cost Remarks  
Hide Section - Interest Areas

Interest Areas

Civil Rights
Food and Drugs
Food and Drugs
Health and Health Research
Medicine and Dentistry


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-040333Advisory Commission on Childhood Vaccines2021
 COM-038612Advisory Commission on Childhood Vaccines2020
 COM-036484Advisory Commission on Childhood Vaccines2019
 COM-034684Advisory Commission on Childhood Vaccines2018
 COM-001728Advisory Commission on Childhood Vaccines2017
 COM-002350Advisory Commission on Childhood Vaccines2016
 COM-004015Advisory Commission on Childhood Vaccines2015
 COM-004442Advisory Commission on Childhood Vaccines2014
 COM-005898Advisory Commission on Childhood Vaccines2013
 COM-006477Advisory Commission on Childhood Vaccines2012
 COM-008045Advisory Commission on Childhood Vaccines2011
 COM-008689Advisory Commission on Childhood Vaccines2010
 COM-010267Advisory Commission on Childhood Vaccines2009
 COM-010662Advisory Commission on Childhood Vaccines2008
 COM-012248Advisory Commission on Childhood Vaccines2007
 COM-012867Advisory Commission on Childhood Vaccines2006
 COM-013983Advisory Commission on Childhood Vaccines2005
 COM-014569Advisory Commission on Childhood Vaccines2004
 COM-015644Advisory Commission on Childhood Vaccines2003
 COM-016782Advisory Commission on Childhood Vaccines2002
 COM-017776Advisory Commission on Childhood Vaccines2001
 COM-018389Advisory Commission on Childhood Vaccines2000
 COM-019539Advisory Commission on Childhood Vaccines1999
 COM-020543Advisory Commission on Childhood Vaccines1998
 COM-021627Advisory Commission on Childhood Vaccines1997